Effectiveness of resveratrol in inducing adeno-associated virus as a potential definitive therapy for SCN5A mutation in Brugada syndrome: a narrative review
Abstract Objectives Brugada syndrome (BrS) is a hereditary channelopathy that affects cardiac electrical signal transmission, with SCN5A gene mutation being the most common cause. Current BrS therapy primarily relies on Implantable Cardioverter Defibrillators, which are limited to arrhythmia prevent...
Saved in:
| Main Authors: | Andin Zahrani Pateda, Andi Alika Azzahra, Kuni Zakiyyah Sumargo, Muchtar Nora Ismail Siregar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-05-01
|
| Series: | The Egyptian Heart Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43044-025-00640-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sex‐Dependent Phenotypic Variability of an SCN5A Mutation: Brugada Syndrome and Sick Sinus Syndrome
by: Yoshiyasu Aizawa, et al.
Published: (2018-09-01) -
Genetic Basis of Brugada Syndrome
by: Xianghuan Xie, et al.
Published: (2025-07-01) -
THE CLINICAL POLYMORPHISM AND TREATMENT STRATEGY IN A LARGE FAMILY WITH BRUGADA SYNDROME
by: S. Saber, et al.
Published: (2014-05-01) -
Brugada Syndrome: Channelopathy and/or Cardiomyopathy
by: Michele Ciabatti, et al.
Published: (2025-06-01) -
MAIN ASPECTS OF BRUGADA SYNDROME
by: V. S. Dulchenko, et al.
Published: (2020-03-01)